GV
Visionary Education Technology Holdings Group Inc

5,389
Mkt Cap
$5.59M
Volume
237,320.00
52W High
$9.60
52W Low
$1.02
PE Ratio
-0.54
GV Fundamentals
Price
$1.34
Prev Close
$1.29
Open
$1.26
50D MA
$1.69
Beta
1.22
Avg. Volume
648,209.78
P/B
0.37
Loading...
Loading...
News
all
press releases
Visionary Holdings (Nasdaq: GV) Launches Stem Cell-Based Anti-Aging Product Line, Accelerating Expansion into Asia's Premium Regenerative Medicine Market
Visionary Holdings (Nasdaq: GV) Launches Stem Cell-Based Anti-Aging Product Line, Accelerating Expansion into Asia's Premium Regenerative Medicine Market Visionary Holdings (Nasdaq: GV) Launches Stem...
PR Newswire·15d ago
News Placeholder
More News
News Placeholder
Visionary Holdings Inc. Announces Successful Leadership Transition: Elite Governance Team Leads the Way, Standardized Structure Empowers High-Quality Development
Visionary Holdings Inc. Announces Successful Leadership Transition: Elite Governance Team Leads the Way, Standardized Structure Empowers High-Quality Development Visionary Holdings Inc. Announces...
PR Newswire·21d ago
News Placeholder
Visionary Holdings Inc. 2025 Annual General Meeting Concludes Successfully: Completes Board Renewal, Anchors New Direction for Compliant Development
Visionary Holdings Inc. 2025 Annual General Meeting Concludes Successfully: Completes Board Renewal, Anchors New Direction for Compliant Development Visionary Holdings Inc. 2025 Annual General...
PR Newswire·26d ago
News Placeholder
Visionary Holdings Inc. Receives Nasdaq Notification Regarding Delayed Form 20-F Filing
Visionary Holdings Inc. Receives Nasdaq Notification Regarding Delayed Form 20-F Filing Visionary Holdings Inc. Receives Nasdaq Notification Regarding Delayed Form 20-F Filing PR Newswire TORONTO...
PR Newswire·1mo ago
News Placeholder
Visionary Holdings Launches Toronto-Based Joint Venture to Drive Global Commercialization of Innovative Stem Cell Therapy for Diabetes Remission, Targeting a $150 Billion Market Opportunity
Visionary Holdings Launches Toronto-Based Joint Venture to Drive Global Commercialization of Innovative Stem Cell Therapy for Diabetes Remission, Targeting a $150 Billion Market Opportunity Visionary...
PR Newswire·1mo ago
News Placeholder
Visionary Completes Controlling Stake in Sikang Health Industry Joint Venture Platform, Deepening Global Layout of TCM Health Preservation
Visionary Completes Controlling Stake in Sikang Health Industry Joint Venture Platform, Deepening Global Layout of TCM Health Preservation Visionary Completes Controlling Stake in Sikang Health...
PR Newswire·1mo ago
News Placeholder
Visionary Holdings (Nasdaq: GV) Secures Global License for Breakthrough Stem Cell Technology Aimed at Diabetes Remission and Potential Complete Cure in a USD 150 Billion Global Market
Visionary Holdings (Nasdaq: GV) Secures Global License for Breakthrough Stem Cell Technology Aimed at Diabetes Remission and Potential Complete Cure in a USD 150 Billion Global Market Visionary...
PR Newswire·1mo ago
News Placeholder
Visionary Holdings Inc. Announces 2025 Annual Meeting of Shareholders
Visionary Holdings Inc. Announces 2025 Annual Meeting of Shareholders Visionary Holdings Inc. Announces 2025 Annual Meeting of Shareholders PR Newswire TORONTO, Oct. 8, 2025 TORONTO, Oct. 8, 2025...
PR Newswire·2mo ago
News Placeholder
Visionary Holdings: Deeply Responding to the Concerns of the Capital Market and Demonstrating Solid Development Strength
Visionary Holdings: Deeply Responding to the Concerns of the Capital Market and Demonstrating Solid Development Strength Visionary Holdings: Deeply Responding to the Concerns of the Capital Market...
PR Newswire·9mo ago
News Placeholder
Visionary Holdings Navigates a New Era of Precision Medicine, Achieving Major Breakthroughs in Targeted Therapy
Visionary Holdings Navigates a New Era of Precision Medicine, Achieving Major Breakthroughs in Targeted Therapy Visionary Holdings Navigates a New Era of Precision Medicine, Achieving Major...
PR Newswire·9mo ago

Latest GV News

View

Advertisement|Remove ads.

Advertisement|Remove ads.